Longevity News

Stiffness of the Extracellular Matrix May Drive Some Age-Related Changes in Gene Expression

Source: Fight Aging! • Published: 27 Aug 2026, 10:22

Stiffness of the Extracellular Matrix May Drive Some Age-Related Changes in Gene Expression

Extracellular matrix stiffness is examined in a lab study as a potential physical trigger of cellular aging, inviting readers to see what that implies for tissue rejuvenation.

Key Takeaways
  • Cells grown on softer hydrogels showed upregulation of longevity‑associated genes compared with stiffer substrates
  • Stiffer hydrogels produced elongated cell morphologies and gene expression patterns characteristic of aging
  • Modulating substrate stiffness reversed the aging‑linked phenotype and increased autophagic activity in cells
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthCalcitonin gene-related peptide promotes mast cell-mediated neuroimmune inflammation through the CALCRL/RAMP1–JAK3–STAT1 axis in rosaceaReports how a neuropeptide-driven signaling axis links sensory nerves to mast cell activation and inflammation in chronic facial skin disease.Frontiers - HealthErgothioneine, collagen peptides, and sodium hyaluronate ameliorate facial skin aging via modulating oxidative stress, inflammation, and extracellular matrix homeostasisProfiles a dual ex vivo and clinical study testing an oral combination of an antioxidant, collagen peptides, and hyaluronate for improving facial skin aging signs and biomarkers.Fight Aging!Age-Related Changes in Metabolism that Contribute to Inflammatory Microglia in the BrainHow metabolic shifts in aging brain immune cells influence their inflammatory behavior — a short review guiding readers through emerging research angles.Frontiers - HealthToward nursing-integrated biomarker surveillance for immune-related adverse events during immune checkpoint inhibitor therapyDescribes nursing-integrated biomarker surveillance strategies to detect immune-related adverse events during immune checkpoint inhibitor therapy and how to operationalize them.